CRISPR/Cas9 technology was used to generate a 1244-bp targeted deletion at the 3' end of the transcribed sequence, including the last 400 bp of the 3' untranslated region (3'-UTR) and the adjacent downstream sequence. (J:94077)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count